Cardioneuroablation for the treatment of symptomatic bradycardia mediated by the cardiac autonomic nervous.
作者信息
Song Zi-Liang, Qin Mu, Liu Xu
机构信息
Department of Cardiology, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
出版信息
J Geriatr Cardiol. 2023 Sep 28;20(9):615-617. doi: 10.26599/1671-5411.2023.09.001.
Abstract
摘要
相似文献
1
Cardioneuroablation for the treatment of symptomatic bradycardia mediated by the cardiac autonomic nervous.心脏神经消融术治疗由心脏自主神经介导的症状性心动过缓
J Geriatr Cardiol. 2023 Sep 28;20(9):615-617. doi: 10.26599/1671-5411.2023.09.001.
2
Cardioneuroablation: Where are we at?心脏神经消融术：我们进展到哪一步了？
Heart Rhythm O2. 2023 Mar 21;4(6):401-413. doi: 10.1016/j.hroo.2023.02.007. eCollection 2023 Jun.
3
Selection of patients with symptomatic vagal-induced sinus node dysfunction: Who will be the best candidate for cardioneuroablation?有症状的迷走神经介导的窦房结功能障碍患者的选择：谁将是心脏神经消融的最佳候选人？
Front Physiol. 2023 Feb 7;14:1088881. doi: 10.3389/fphys.2023.1088881. eCollection 2023.
4
Cardioneuroablation for vasovagal syncope and atrioventricular block: A step-by-step guide.用于血管迷走性晕厥和房室传导阻滞的心神经消融术：分步指南
J Cardiovasc Electrophysiol. 2022 Oct;33(10):2205-2212. doi: 10.1111/jce.15480. Epub 2022 Apr 9.
5
Long-Term Evaluation of the Vagal Denervation by Cardioneuroablation Using Holter and Heart Rate Variability.使用 Holter 监测和心率变异性评估心脏去神经支配的长期效果。
Circ Arrhythm Electrophysiol. 2020 Dec;13(12):e008703. doi: 10.1161/CIRCEP.120.008703. Epub 2020 Nov 16.
6
Right anterior ganglionated plexus: The primary target of cardioneuroablation?右侧前神经节丛：心脏神经消融的主要靶点？
Heart Rhythm. 2019 Oct;16(10):1545-1551. doi: 10.1016/j.hrthm.2019.07.018. Epub 2019 Jul 19.
7
Shared Decision Making and Cardioneuroablation Allow Discontinuation of Permanent Pacing in Patients with Vagally Mediated Bradycardia.共同决策与心脏神经消融术可使迷走神经介导的心动过缓患者停用永久性起搏器
J Cardiovasc Dev Dis. 2023 Sep 11;10(9):392. doi: 10.3390/jcdd10090392.
8
Potential usage of cardioneuroablation in vagally mediated functional atrioventricular block.心脏神经消融术在迷走神经介导的功能性房室传导阻滞中的潜在应用。
SAGE Open Med. 2019 Mar 15;7:2050312119836308. doi: 10.1177/2050312119836308. eCollection 2019.
9
Clinical impact of aging on outcomes of cardioneuroablation for reflex syncope or functional bradycardia: Results from the cardionEuroabLation: patiEnt selection, imaGe integrAtioN and outComEs-The ELEGANCE multicenter study.心脏神经消融术治疗反射性晕厥或功能性心动过缓的临床效果与年龄的关系：来自心脏神经消融术：患者选择、影像整合和结果-elegance 多中心研究的结果。
Heart Rhythm. 2023 Sep;20(9):1279-1286. doi: 10.1016/j.hrthm.2023.06.007. Epub 2023 Jun 15.
10
Treatment of Symptomatic Functional Atrioventricular Block by Cardioneuroablation as an Alternative to Pacemaker Implantation.心脏神经消融术治疗有症状的功能性房室传导阻滞作为起搏器植入的替代方法
JACC Case Rep. 2022 Aug 3;4(15):990-995. doi: 10.1016/j.jaccas.2022.04.029.
引用本文的文献
1
Cardioneuroablation for reflex syncope or functional bradyarrhytmias: new insight from a single center experience.用于反射性晕厥或功能性缓慢性心律失常的心脏神经消融术：来自单中心经验的新见解
Front Cardiovasc Med. 2025 Jan 13;11:1526825. doi: 10.3389/fcvm.2024.1526825. eCollection 2024.
2
Cardioneuroablation for the management of neurally mediated syncope, sinus bradycardia, and atrioventricular block.心脏神经消融术用于治疗神经介导性晕厥、窦性心动过缓和房室传导阻滞。
J Interv Card Electrophysiol. 2025 Mar;68(2):281-292. doi: 10.1007/s10840-024-01923-7. Epub 2024 Sep 27.
本文引用的文献
1
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.2021年欧洲心脏病学会心脏起搏与心脏再同步治疗指南。
Eur Heart J. 2021 Sep 14;42(35):3427-3520. doi: 10.1093/eurheartj/ehab364.
2
2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.2018年美国心脏病学会/美国心脏协会/心律学会关于心动过缓和心脏传导延迟患者评估与管理的指南：美国心脏病学会/美国心脏协会临床实践指南工作组及心律学会的报告
Circulation. 2019 Aug 20;140(8):e382-e482. doi: 10.1161/CIR.0000000000000628. Epub 2018 Nov 6.
3
Ablation of Atrial Gangionated Plexi to Treat Symptomatic Sinus Bradycardia.消融心房神经节丛治疗症状性窦性心动过缓
JACC Clin Electrophysiol. 2017 Sep;3(9):960-961. doi: 10.1016/j.jacep.2017.02.010. Epub 2017 May 31.
4
Atrial Ganglionated Plexus Modification: A Novel Approach to Treat Symptomatic Sinus Bradycardia.心房神经丛修饰术：治疗症状性窦性心动过缓的新方法。
JACC Clin Electrophysiol. 2017 Sep;3(9):950-959. doi: 10.1016/j.jacep.2017.01.022. Epub 2017 Apr 26.
5
Atrial Ganglionated Plexus Modification: A Novel Approach to Treat Symptomatic Sinus Bradycardia.心房神经节丛改良术：一种治疗症状性窦性心动过缓的新方法。
JACC Clin Electrophysiol. 2018 Feb;4(2):287-288. doi: 10.1016/j.jacep.2017.10.015. Epub 2018 Feb 19.
6
"Cardioneuroablation"--new treatment for neurocardiogenic syncope, functional AV block and sinus dysfunction using catheter RF-ablation.“心脏神经消融术”——一种使用导管射频消融术治疗神经心源性晕厥、功能性房室传导阻滞和窦房结功能障碍的新疗法。
Europace. 2005 Jan;7(1):1-13. doi: 10.1016/j.eupc.2004.10.003.
7
Unexplained sinus bradycardia: clinical significance and long-term prognosis in apparently healthy persons older than 40 years.不明原因的窦性心动过缓：40岁以上貌似健康人群的临床意义及长期预后
Am J Cardiol. 1986 Nov 1;58(10):1009-13. doi: 10.1016/s0002-9149(86)80029-7.
Zotero 插件